Evidence map›Paper›PMID 33480204›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2021

Ocular Involvement Occurs Frequently at All Stages of Amyotrophic Lateral Sclerosis: Preliminary Experience in a Large Italian Cohort.

Federica Cozza, Andrea Lizio, Lucia Catherine Greco, Stefania Bona, Giordana Donvito, Elena Carraro, Silvia Tavazzi, Nicola Ticozzi, Barbara Poletti, Valeria Ada Sansone and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Federica Cozza *Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-8854-5632
Andrea Lizio *Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-8875-9665
Lucia Catherine GrecoNeuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0003-3659-4034
Stefania BonaNeuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-3590-7046
Giordana DonvitoNeuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-9651-2769
Elena CarraroNeuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-1259-1050
Silvia TavazziMaterials Science Department & COMiB Research Center, University of Milano Bicocca, Milan, Italy.ORCID https://orcid.org/0000-0001-5786-2021
Nicola TicozziDepartment of Neurology and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0001-5963-7426
Barbara PolettiDepartment of Neurology and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0003-4398-2051
Valeria Ada SansoneNeuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-1354-3800
Christian LunettaNeuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.ORCID https://orcid.org/0000-0002-4788-1875
Centro Clinico Nemo · ITUniversity of Milan · ITIRCCS Istituto Auxologico Italiano · ITUniversity of Milano-Bicocca · IT

Funding

Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
6 · The paper itself

Abstract

background and purposeThe study aimed to obtain optometric findings of amyotrophic lateral sclerosis (ALS) patients in different stages of the disease, and to determine the relation between ocular data and ALS-related features; that is, functional and cognitive impairment and staging.

methodsThe optometric protocol included tests of the ocular motility [broad-H test and Northeastern State University College of Optometry (NSUCO) test], near point of convergence (NPC), error refraction, best-corrected visual acuity, and binocular visual alignment, and an ocular symptoms questionnaire. The functional measures included the Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-r) and Milano-Torino staging (MiToS), and cognitive impairment was assessed using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Demographic and clinical features were also collected, including whether the patients used an eye-tracking communication device (ETCD).

resultsTwo-hundred consecutive ALS patients (median age of 64 years, 118 males and 82 females) in different stages of disease were recruited. Nearly 70% of patients reported at least one ocular symptom, and the use of an ETCD was found to be significantly related to the presence of most symptoms. Moreover, the severely symptomatic group was characterized by significantly lower ALSFRS-r total and subscale scores, and higher MiToS. Abnormal NPC values were significantly related to lower ALSFRS-r total and bulbar-subscale scores. Patients with acceptable NSUCO test values exhibited significantly higher ECAS scores.

conclusionsThe presence of ocular alteration in patients in different stages of ALS supports the idea that this is a multisystem disorder and emphasizes the importance of optometric evaluations in multidisciplinary assessments to address ocular impairment early in the disease process.

Indexed as

amyotrophic lateral sclerosisEdinburgh Cognitive and Behavioural ALS ScreenMilano-Torino stagingocular motilityoptometric analysisvisual system

Identifiers

PMID33480204
PMCPMC7840315
OpenAlexW3123261540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.